These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27995486)

  • 1. Clostridium difficile infection: Updates in management.
    Tariq R; Khanna S
    Indian J Gastroenterol; 2017 Jan; 36(1):3-10. PubMed ID: 27995486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile Colitis Prevention and Treatment.
    Dinleyici M; Vandenplas Y
    Adv Exp Med Biol; 2019; 1125():139-146. PubMed ID: 30689174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile infection: review.
    Czepiel J; Dróżdż M; Pituch H; Kuijper EJ; Perucki W; Mielimonka A; Goldman S; Wultańska D; Garlicki A; Biesiada G
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1211-1221. PubMed ID: 30945014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics.
    Dicks LMT; Mikkelsen LS; Brandsborg E; Marcotte H
    Curr Microbiol; 2019 Jun; 76(6):774-782. PubMed ID: 30084095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches to treating Clostridium difficile-associated colitis.
    Padua D; Pothoulakis C
    Expert Rev Gastroenterol Hepatol; 2016; 10(2):193-204. PubMed ID: 26643655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Refractory colitis by Clostridium difficile treated with fecal microbiota transplant].
    Martínez JV; Raush A; Efrón ED; Zubiaurre I; Pinoni MV; Giorgio PL; Eusebio MJ; Verbanaz SC; Jordan R
    Medicina (B Aires); 2019; 79(4):291-294. PubMed ID: 31487251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs and strategies for management of Clostridium difficile colitis.
    Higa JT; Kelly CP
    J Intensive Care Med; 2014; 29(4):190-9. PubMed ID: 23753229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.
    Mizusawa M; Doron S; Gorbach S
    Drugs Aging; 2015 Aug; 32(8):639-47. PubMed ID: 26233437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of
    Eliakim-Raz N; Bishara J
    Hum Vaccin Immunother; 2019; 15(6):1453-1456. PubMed ID: 29781761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of probiotics in the prevention and treatment of antibiotic-associated diarrhea and Clostridium difficile colitis.
    Friedman G
    Gastroenterol Clin North Am; 2012 Dec; 41(4):763-79. PubMed ID: 23101686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.
    Cammarota G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2014 Sep; 48(8):693-702. PubMed ID: 24440934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection: A brief update on emerging therapies.
    Goldberg EJ; Bhalodia S; Jacob S; Patel H; Trinh KV; Varghese B; Yang J; Young SR; Raffa RB
    Am J Health Syst Pharm; 2015 Jun; 72(12):1007-12. PubMed ID: 26025991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperimmune bovine colostrum as a novel therapy to combat Clostridium difficile infection.
    Sponseller JK; Steele JA; Schmidt DJ; Kim HB; Beamer G; Sun X; Tzipori S
    J Infect Dis; 2015 Apr; 211(8):1334-41. PubMed ID: 25381448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current knowledge on the laboratory diagnosis of
    Martínez-Meléndez A; Camacho-Ortiz A; Morfin-Otero R; Maldonado-Garza HJ; Villarreal-Treviño L; Garza-González E
    World J Gastroenterol; 2017 Mar; 23(9):1552-1567. PubMed ID: 28321156
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
    Hota SS; Sales V; Tomlinson G; Salpeter MJ; McGeer A; Coburn B; Guttman DS; Low DE; Poutanen SM
    Clin Infect Dis; 2017 Feb; 64(3):265-271. PubMed ID: 28011612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.